BRIDGEWATER, N.J., June 18, 2024 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Shanghai Stock Exchange: 603087) announced today the presentation of three abstracts featuring their investigational products at the American Diabetes Association's (ADA's[1]) 84th Scientific Sessions. The meeting will be held in-person and virtually from June 21-24, 2024, in Orlando, Florida .
All abstracts will be published on the journal Diabetes® website. Data from the selected studies will be presented live on June 22, from 12:30-1:30 PM EDT in the Poster Hall.
The above abstracts and presentations represent the data that will be showcased or published by Gan & Lee. This press release includes forward-looking statements regarding investigational products currently in development by Gan & Lee. It is important to note that there are risks associated with drug development, and there is no guarantee that future studies will produce results consistent with those presented at the ADA's 84th Scientific Sessions.
References:
[1]. ADA's 84th Scientific Sessions. https://professional.diabetes.org/scientific-sessions
[2]. Zhang M, Zhang Y, Peng X, et al. GZR18, a novel long-acting GLP-1 analog, demonstrated positive in vitro and in vivo pharmacokinetic and pharmacodynamic characteristics in animal models. Eur J Pharmacol. 2022;928:175107. doi:10.1016/j.ejphar.2022.175107
About Gan & Lee
Gan & Lee Pharmaceuticals developed the first Chinese domestic insulin analog. Currently, Gan & Lee has six core insulin products, including five insulin analog varieties: long-acting glargine injection (Basalin®), fast-acting lispro injection (Prandilinâ„¢), fast-acting aspart injection (Rapilin®), mixed protamine zinc lispro injection (25R) (Prandilinâ„¢25), aspart 30 injection (Rapilin®30), and one human insulin injection - mixed protamine human insulin injection (30R) (Similin®30). The company has two approved medical devices in China, namely reusable insulin injection pen (GanleePen), and disposable pen needle (GanleeFine®).
In China's second Volume Based Procurement (VBP) in 2024, Gan & Lee Pharmaceuticals ranked second overall and first among domestic companies in terms of procurement demand for insulin analogs. The company is also making strides in international markets, with the disposable pen needle (GanleeFine®) approved by the US Food and Drug Administration (FDA) in 2020 and received GMP inspection approval from the European Medicines Agency (EMA) in 2024. These achievements significantly boost Gan & Lee's competitiveness in both international and domestic markets.
In the future, Gan & Lee will strive for comprehensive coverage in diabetes treatment. Moving forward with its mission to become a world-class pharmaceutical company, Gan & Lee will also actively develop new chemical entities and biological drugs, focusing on treatments for metabolic diseases, cardiovascular diseases, and other therapeutic areas.
Further Information
BPRD@ganlee.com（Media）
BD@ganlee.com（Business Development）
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Gan & Lee Pharmaceuticals to Present Groundbreaking Data on Three Innovative Products at the American Diabetes Association's 84th Scientific Sessions
Gan & Lee Pharmaceuticals to Present Groundbreaking Data on Three Innovative Products at the American Diabetes Association's 84th Scientific Sessions
Gan & Lee Pharmaceuticals to Present Groundbreaking Data on Three Innovative Products at the American Diabetes Association's 84th Scientific Sessions
Gan & Lee Pharmaceuticals to Present Groundbreaking Data on Three Innovative Products at the American Diabetes Association's 84th Scientific Sessions
SINGAPORE, April 23, 2025 /PRNewswire/ -- From April 14 to 18, 2025, FlexTV — the short drama platform under Mega Matrix Inc. (NYSE American: MPU) — launched six new English short dramas, further solidifying its leading position in the global vertical drama landscape. Packed with high-stakes family feuds, twisted revenge arcs, and forbidden romances, the new titles reflect FlexTV's commitment to delivering emotionally resonant and genre-diverse content to global audiences.
From mistaken-identity romance contracts to interspecies guardianship across social boundaries, this week's lineup caters to a broad spectrum of emotional experiences and underlines the platform's dedication to building a globally resonant short drama ecosystem.
Quick Look: New Releases
April 14 — Fake Husband, Real Sparks
Charles, a wealthy heir plotting revenge, is mistaken for a popular bartender and enters a bizarre "sugar daddy" contract with Jennie. As their relationship deepens, secrets unravel — all tied to a deeper power struggle within the elite.
April 15 — I Am The Real Heiress
After the adopted daughter Lisa climbs to the top through arson and betrayal, the real heiress Vivian returns with a new face and a plan for revenge. The drama challenges conventional notions of blood ties and class hypocrisy.
April 16 — Pregnant With My Rival CEO's Baby
Vivian, a career-driven woman battling infertility, parts ways with her toxic ex — only to end up pregnant by her fiercest business rival, Leo. With complex power dynamics and emotional stakes, the show delves into female agency over fertility and ambition.
April 17 — Small, Smart & Slightly Evil
Victoria, a humble lunch vendor, finds herself rescued by CEO Wyatt and catapulted into high society. With his support, she takes on her enemies and builds a life of both love and success.
April 18 — Double Drama Drop：
Entertainment Meets Real-World Reflections
Beyond gripping plot twists, this week's releases subtly reflect pressing societal themes:
With compelling narratives and emotional depth, FlexTV continues to deliver both entertainment and social reflection — sparking conversations alongside storytelling.
Available in 15 languages including English, Japanese, and Korean, FlexTV reaches viewers in over 100 countries and regions. As it continues to innovate and diversify its content offerings, FlexTV remains committed to providing a premium viewing experience for audiences around the world. For more captivating series, visit https://www.flextv.cc/.
About Mega Matrix Inc.: Mega Matrix Inc. (NYSE American: MPU) is a holding company and operates FlexTV, a short-video streaming platform and producer of short dramas, through Yuder Pte, Ltd., an indirect wholly owned subsidiary of the Company. Mega Matrix Inc. is a Cayman Islands corporation headquartered in Singapore. For more information, please contact info@megamatrix.io or visit: http://www.megamatrix.io.
Key Metrics
The numbers for our key metrics, which include our period active users (PAU), period paying users (PPU), average membership and top-up streaming service revenue per active user (ARPU), and average membership and top-up streaming service revenue per paying user (ARPPU), are calculated using internal company data based on the activity of user accounts. We define an active user as a user who has downloaded and opened the FlexTV app at least once. We define a paying user as a user who has registered for a membership or has topped up, provided a method of payment, and is entitled to access FlexTV services (this membership or topping up does not include participation in free trials or other promotional offers extended by FlexTV to new users). We define ARPU as average membership and top-up streaming services revenue generated by each active user in one quarter. We define ARPPU as average membership and top-up streaming services revenue generated by each paying user in one quarter. We use these metrics to assess the growth and health of the overall business and believe that ARPU best reflects our ability to attract, retain, engage and monetize our users, and thereby drive revenue. While these numbers are based on what we believe to be reasonable estimates of our user base for the applicable period of measurement, there are inherent challenges in measuring usage of our products across large online and mobile populations around the world. In addition, we are continually seeking to improve our estimates of our user base, and such estimates may change due to improvements or changes in technology or our methodology.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. All statements in this press release other than statements that are purely historical are forward looking statements. When used in this press release, the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "should," "future," "propose," and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees for future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, are: the ability to manage growth; ability to identify and integrate future acquisitions; ability to grow and expand our FlexTV business; ability to obtain additional financing in the future to fund capital expenditures; fluctuations in general economic and business conditions; costs or other factors adversely affecting the Company's profitability; litigation involving patents, intellectual property, and other matters; potential changes in the legislative and regulatory environment; a pandemic or epidemic; the possibility that the Company may not succeed in developing its new lines of businesses due to, among other things, changes in the business environment, competition, changes in regulation, or other economic and policy factors; and the possibility that the Company's new lines of business may be adversely affected by other economic, business, and/or competitive factors. The forward-looking statements in this press release and the Company's future results of operations are subject to additional risks and uncertainties set forth under the heading "Risk Factors" in documents filed by the Company with the Securities and Exchange Commission ("SEC"), including the Company's latest annual report on Form 20-F, filed with the SEC on March 28, 2025, and are based on information available to the Company on the date hereof. In addition, such risks and uncertainties include the Company's inability to predict or control bankruptcy proceedings and the uncertainties surrounding the ability to generate cash proceeds through the sale or other monetization of the Company's assets. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this press release.
Disclosure Channels
We announce material information about the Company and its services and for complying with our disclosure obligation under Regulation FD via the following social media channels:
X (f/k/a Twitter):
twitter.com/MegaMatrixMPU
Facebook:
facebook.com/megamatrixmpu
facebook.com/flextvus
LinkedIn:
linkedin.com/company/megamatrixmpu
TikTok:
tiktok.com/@flextv_english
YouTube:
youtube.com/@FlexTV_English
The Company will also use its landing page on its corporate website (www.megamatrix.io) to host social media disclosures and/or links to/from such disclosures. The information we post through these social media channels may be deemed material. Accordingly, investors should monitor these social media channels in addition to following our website, press releases, SEC filings and public conference calls and webcasts. The social media channels that we intend to use as a means of disclosing the information described above may be updated from time to time as listed on our website.
For inquiries, please contact: Info@megamatrix.io
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Mega Matrix Inc. Released Six New Short Dramas on FlexTV (April 14-18), Where Love, Lies, and Legacy Unfold
